Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Prebiotin is an all-natural, plant-based, full-spectrum prebiotic fiber supplement designed to nourish beneficial gut bacteria and support digestive health. Its primary active ingredient is oligofructose-enriched inulin (OEI), a combination of inulin and oligofructose derived from chicory root. This blend has been shown to more effectively stimulate the growth of beneficial bacteria throughout the colon than either component alone. By promoting a healthy gut microbiome, Prebiotin supports bowel regularity, enhances stool softness and frequency, increases calcium absorption for stronger bone density, improves immunity, aids cardiovascular health, assists with weight management and appetite control, corrects colon dysbiosis and leaky gut syndrome, reduces smelly gas production by altering colonic acidity, and may help manage conditions such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). The product is manufactured according to FDA Good Manufacturing Practice standards[1][2][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Prebiotin.